Topical NVN1000 for the Treatment of External Genital and Perianal Warts
Public ClinicalTrials.gov record NCT02462187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-center, Double-blind, Randomized, Vehicle-controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects With External Genital Warts and Perianal Warts
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects with External Genital Warts and Perianal Warts
Study identification
- NCT ID
- NCT02462187
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2015 (Actual)
- Primary completion
- Oct 2016 (Actual)
- Completion
- Oct 17, 2016 (Actual)
- Last update posted
- Apr 6, 2023
2015 – 2016
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| PPD 137 | Fountain Valley | California | 92708 | — |
| PPD 140 | Lomita | California | 90717 | — |
| PPD 133 | San Diego | California | 92123 | — |
| PPD 134 | Atlanta | Georgia | 30005 | — |
| PPD 139 | Atlanta | Georgia | 30338 | — |
| PPD 138 | Roswell | Georgia | 30075 | — |
| PPD 130 | Indianapolis | Indiana | 46202 | — |
| PPD 126 | Metairie | Louisiana | 70006 | — |
| PPD 132 | Portland | Oregon | 97210 | — |
| PPD 135 | Philadelphia | Pennsylvania | 19107 | — |
| PPD 128 | Corpus Christi | Texas | 78414 | — |
| PPD 129 | Houston | Texas | 77023 | — |
| PPD 127 | San Antonio | Texas | 78229 | — |
| PPD 131 | Webster | Texas | 75598 | — |
| PPD 136 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02462187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02462187 live on ClinicalTrials.gov.